CompanyDrug

Phanes Therapeutics’ PT886 Receives CDE Approval for Clinical Trials in Advanced Solid Tumors

CompanyDrug

ImmunoTech Biopharm Gets NMPA Green Light for Clinical Study of aT19 Injection for B-ALL

Policy / Regulatory

Beijing, Tianjin, and Hebei Release Draft Proposal for Updated Drug Clinical Trial Inspection Standards

CompanyDrug

AstraZeneca’s Tagrisso Wins Expanded FDA Approval for EGFR-mutated NSCLC

CompanyDrug

Innovent Biologics’ IBI311 Achieves Primary Endpoint in Phase III Study for Thyroid Eye Disease

Policy / Regulatory

China’s CDE Issues Guiding Principles for ADC Research and Evaluation

CompanyLegal / IP

GSK and Peers Respond to FTC Criticism, Withdraw Patent Listings from US Orange Book

CompanyDeals

Astellas Pharma Partners with Kelonia Therapeutics to Advance CAR-T Cell Therapies

CompanyDrug

Denali Therapeutics Faces Setback as ALS Trial Fails to Meet Primary Endpoint

Policy / Regulatory

China’s NMPA Releases 77th Batch of Reference Drugs for Generic Quality Evaluation

Policy / Regulatory

GSK’s Avodart Receives NMPA Approval to Resume Sales in China from September

Policy / Regulatory

National Health Commission Notification Signals New Poliovirus Containment Measures